UY31095A1 - PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT - Google Patents

PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT

Info

Publication number
UY31095A1
UY31095A1 UY31095A UY31095A UY31095A1 UY 31095 A1 UY31095 A1 UY 31095A1 UY 31095 A UY31095 A UY 31095A UY 31095 A UY31095 A UY 31095A UY 31095 A1 UY31095 A1 UY 31095A1
Authority
UY
Uruguay
Prior art keywords
agent
pharmaceutical composition
combination
convulsive
viral
Prior art date
Application number
UY31095A
Other languages
Spanish (es)
Inventor
Victor Guillermo Alvarez Ochoa
Josefina Santos Murillo
Maria Elena Garcia Armenta
Original Assignee
World Trade Imp Export Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40032120&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY31095(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by World Trade Imp Export Wtie Ag filed Critical World Trade Imp Export Wtie Ag
Publication of UY31095A1 publication Critical patent/UY31095A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invencion está relacionada con una composicion farmacéutica compuesta por la combinacion sinérgica de un agente anticonvulsivo como lo es el principio activo: Gabapentina y un agente antiviral como lo es el principio activo: Aciclovir; los cuales se encuentran formulados en una sola unidad de dosifiacion para ser formulados en una sola unidad de dosifiacion para ser administrada por vía oral, misma que está indicada para la prevencion y/o el tratamiento de la Neuralgia Post-herpética.The present invention is related to a pharmaceutical composition composed of the synergistic combination of an anticonvulsant agent such as the active ingredient: Gabapentin and an antiviral agent such as the active ingredient: Aciclovir; which are formulated in a single dosage unit to be formulated in a single dosage unit to be administered orally, which is indicated for the prevention and / or treatment of Post-herpetic Neuralgia.

UY31095A 2007-05-21 2008-05-19 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT UY31095A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2007006093A MX2007006093A (en) 2007-05-21 2007-05-21 Pharmaceutical composition combining an anticonvulsant agent and an antiviral agent.

Publications (1)

Publication Number Publication Date
UY31095A1 true UY31095A1 (en) 2008-11-28

Family

ID=40032120

Family Applications (1)

Application Number Title Priority Date Filing Date
UY31095A UY31095A1 (en) 2007-05-21 2008-05-19 PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT

Country Status (7)

Country Link
AR (1) AR066668A1 (en)
CL (1) CL2008001476A1 (en)
CO (1) CO6241103A2 (en)
MX (1) MX2007006093A (en)
PE (1) PE20090292A1 (en)
UY (1) UY31095A1 (en)
WO (1) WO2008143490A1 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ508489A (en) * 1998-07-09 2004-06-25 Warner Lambert Co Pharmaceutical composition containing GABA analogs and an antiviral agent to treat shingles

Also Published As

Publication number Publication date
CL2008001476A1 (en) 2008-07-11
MX2007006093A (en) 2009-02-25
WO2008143490A1 (en) 2008-11-27
AR066668A1 (en) 2009-09-02
CO6241103A2 (en) 2011-01-20
PE20090292A1 (en) 2009-04-04

Similar Documents

Publication Publication Date Title
AR048705A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF SEXUAL DISORDERS II
ECSP066990A (en) FORMULATIONS WITH CONTROLLED RELEASE OF ACTIVE PRINCIPLE CONTAINING VARDENAFILO
AR070026A1 (en) SET OF ELEMENTS FOR THE DOSAGE OF 1-AMINO-ALQUILCICLOHEXANOS, SUCH AS NERAMEXAN, AND TREATMENT OF DIFFERENT DISEASES INCLUDING TINNITUS
PE20150773A1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE SUSTAINED RELEASE OF PHENYLEPHRINE
ECSP099734A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN NON-STEROID ANTI-INFLAMMATORY AGENT AND AN ANTI-CONVULSIVING AGENT
CO6280474A2 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF EFFECTIVE EJACULATION
BR112012030654A2 (en) bendamustine oral dosage forms
PE20130147A1 (en) PHARMACEUTICAL COMBINATION OF THEOBROMINE AND A NON-OPIOID ANTITUSSIVE AGENT
CO2020001887A2 (en) Synergistic pharmaceutical combination of the active enantiomer s-ketorolac and gabapentin for the treatment of neuropathic pain
GT200800208A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A KETOROLACO SALT AND VITAMINS OF COMPLEX B FOR THE TREATMENT OF NEURALGIA.
AR080541A1 (en) TREATMENT FOR ENDOMETRIOSIS
ECSP11010941A (en) PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT OF SEXUAL TRANSMISSION INFECTIONS
UY31095A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND AN ANTI-VIRAL AGENT
SV2009003324A (en) PHARMACEUTICAL PREPARATION TO REDUCE ENDOMETRIOSIS
PE20090316A1 (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS
AR066667A1 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THE COMBINATION OF A HYDROGEN DERIVATIVE LIPSTATINE AGENT AND AN HMG COA REDUCTASA INHIBITING AGENT
ECSP109877A (en) PHARMACEUTICAL COMPOSITION INCLUDING THE COMBINATION OF AN ANTI-CONVULSIVE AGENT AND A BENZODIAZEPINIC AGENT, INDICATED FOR THE CONTROL AND TREATMENT OF CONVULSIVE DISORDERS AND EPILEPTIC SYNDROMES
ECSP099801A (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF AN INHIBITING AGENT OF THE HMG-CoA REDUCTASE ENZYME AND AN INHIBITING AGENT OF THE GASTROINTESTINAL LIPASE ENZYME
UY31212A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A BENZISOXAZOLIC DERIVATIVE AGENT AND A BENZODIAZEPINIC AGENT
UA113237U (en) PHARMACEUTICAL COMBINATION OF ACECLOPHENAC AND SODIUM OR ANALYTING COMPONENT
UY31107A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS.
ECSP109996A (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND A SELECTIVE INHIBITING AGENT OF THE ENCEPHALINASE ENZYME, INDICATED FOR THE CONTROL AND TREATMENT OF THE ACUTE BACTERIAL DIARRHEA
UY31157A1 (en) PHARMACEUTICAL COMPOSITION UNDERSTANDING THE COMBINATION OF AN INHIBITING AGENT OF THE HMG-COA REDUCTASE ENZYME AND AN INHIBITING AGENT OF THE GASTRONTESTINAL ENZYME LIPASA
AR071736A1 (en) PHARMACEUTICAL COMPOSITION COMPOSED BY THE COMBINATION OF VARIOUS ANTISPASMODIC AGENTS AND AN NON-STEROID ANTI-INFLAMMATORY AGENT, USEFUL FOR THE CONTROL AND TREATMENT OF RENAL COLICO AND INFLAMMATION
AR090009A1 (en) STIMULANT PHARMACEUTICAL COMPOSITION OF S-ADENOSILMETIONINE BIOSYNTHESIS

Legal Events

Date Code Title Description
104 Application deemed to be withdrawn (no substantive examination fee paid)

Effective date: 20170913